| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| VALERITAS Aktie jetzt für 0€ handeln |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| UNITEDHEALTH | 276,20 | +0,07 % | Wochenend-Analyse: Unitedhealth-Aktie vor entscheidender Woche - Montag könnte alles ändern! | ||
| THERMO FISHER | 491,15 | +1,76 % | Favorable Results and Improved Guidance Lifted Thermo Fisher Scientific (TMO) in Q3 | ||
| TELADOC HEALTH | 6,056 | -2,07 % | HIMS vs. TDOC: Which Telehealth Stock Looks More Compelling? | ||
| ROKU | 92,81 | -2,10 % | Nielsen To Incorporate Roku's Data Into Its Advanced Campaign Measurement And Outcome Solutions | WASHINGTON (dpa-AFX) - Nielsen, a global data, analytics, and audience measurement company, has expanded its long-term strategic partnership with Roku, Inc. (ROKU) to incorporate the latter's... ► Artikel lesen | |
| RESMED | 208,40 | 0,00 % | Resmed Gets FDA Clearance For Personalized Therapy Comfort Settings; To Be Marketed As Smart Comfort | WASHINGTON (dpa-AFX) - Resmed (RMD, RMD.AX), Monday announced it has received U.S. Food and Drug Administration (FDA) clearance for Personalized Therapy Comfort Settings (PTCS), to be marketed... ► Artikel lesen | |
| HENRY SCHEIN | 65,64 | -0,21 % | HENRY SCHEIN INC explodiert - ich greife jetzt zu! | ||
| ZIMMER BIOMET | 76,00 | +0,08 % | Bactiguard Holding AB: Bactiguard announces updated trauma license agreement with Zimmer Biomet | Bactiguard continues the collaboration with Zimmer Biomet in an updated agreement, giving Zimmer Biomet non-exclusive rights to continue to commercialize the ZNN Bactiguard coated trauma nail system... ► Artikel lesen | |
| PETMED EXPRESS | 2,869 | -6,09 % | PetMed Express, Inc.: PetMed Express Comments on Unsolicited and Non-Binding Acquisition Proposal Received From SilverCape Investments Limited | DELRAY BEACH, Fla., Dec. 11, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc., d/b/a PetMeds and parent company of PetCareRx, (Nasdaq: PETS) (the "Company" or "PetMeds"), today confirmed that it has... ► Artikel lesen | |
| SONOMA PHARMACEUTICALS | 2,480 | -100,00 % | Sonoma Pharmaceuticals, Inc.: National Rosacea Society Awards Seal of Acceptance to Sonoma Pharmaceuticals for Reliefacyn Advanced | BOULDER, CO / ACCESS Newswire / November 13, 2025 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochlorous... ► Artikel lesen | |
| TANDEM DIABETES | 19,550 | +4,55 % | Tandem Diabetes upgraded, Zimmer, ResMed downgraded as Baird previews MedTech in 2026 | ||
| ASENSUS SURGICAL | - | - | GlobalLogic, Asensus ink surgical robotics engineering collab | ||
| QUIDELORTHO | 24,000 | -4,76 % | QuidelOrtho Corporation: QuidelOrtho Reports Third Quarter 2025 Financial Results | ? Total revenue of $700 million; excluding COVID-19 and Donor Screening, revenue grew mid-single digits, demonstrating solid underlying growth and momentum ? ... ► Artikel lesen | |
| VERU | 2,400 | +2,56 % | Veru Inc.: Veru Reports Fiscal Year 2025 Financial Results and Clinical Program Progress | -- Following positive efficacy and safety results from Phase 2b QUALITY study, company received FDA regulatory clarity for enobosarm in combination with GLP-1 RA -- -- Incremental weight loss is an... ► Artikel lesen | |
| QUEST DIAGNOSTICS | 149,00 | -0,20 % | Is Quest Diagnostics Stock a Right Pick for Your Portfolio Now? | ||
| TEMPEST THERAPEUTICS | 6,010 | -100,00 % | Tempest Therapeutics: Tempest Announces Strategic Acquisition of New Dual-CAR T Programs from Factor with Simultaneous Runway Extension Projected to Mid 2027 | All-stock acquisition includes clinical-stage CD19/BCMA Dual-CAR T programAcquisition will expand existing advanced clinical-stage pipeline of amezalpat (PPAR- Antagonist, Phase 3-ready) and TPST-1495... ► Artikel lesen |